BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2910219)

  • 1. Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Arch Gen Psychiatry; 1989 Jan; 46(1):13-9. PubMed ID: 2910219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.
    Cowen PJ; McCance SL; Cohen PR; Julier DL
    Psychopharmacology (Berl); 1989; 99(2):230-2. PubMed ID: 2508159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Am J Psychiatry; 1991 Nov; 148(11):1518-25. PubMed ID: 1928466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan depletion in lithium-stabilized patients with affective disorder.
    Johnson L; El-Khoury A; Aberg-Wistedt A; Stain-Malmgren R; Mathé AA
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):329-36. PubMed ID: 11806858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.
    Price LH; Charney DS; Delgado PL; Anderson GM; Heninger GR
    Arch Gen Psychiatry; 1989 Jul; 46(7):625-31. PubMed ID: 2500111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
    Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
    J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
    Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ; McCance SL; Ware CJ; Cohen PR; Chalmers JS; Julier DL
    Br J Psychiatry; 1991 Sep; 159():341-6. PubMed ID: 1659918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects.
    Manji HK; Hsiao JK; Risby ED; Oliver J; Rudorfer MV; Potter WZ
    Arch Gen Psychiatry; 1991 Jun; 48(6):505-12. PubMed ID: 1645513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium treatment effect on serotonin function.
    Glue P; Nutt DJ
    Arch Gen Psychiatry; 1990 Mar; 47(3):289-90. PubMed ID: 2306169
    [No Abstract]   [Full Text] [Related]  

  • 12. The unipolar-bipolar depressive dichotomy and the relationship between afternoon prolactin and cortisol levels.
    Joyce PR; Sellman JD; Donald RA; Livesey JH; Elder PA
    J Affect Disord; 1988; 14(2):189-93. PubMed ID: 2966833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
    Glue PW; Cowen PJ; Nutt DJ; Kolakowska T; Grahame-Smith DG
    Psychopharmacology (Berl); 1986; 90(3):398-402. PubMed ID: 3097730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin response to tryptophan during mianserin treatment.
    Cowen PJ
    Am J Psychiatry; 1988 Jun; 145(6):740-1. PubMed ID: 3369564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium increases 5-HT-mediated prolactin release.
    McCance SL; Cohen PR; Cowen PJ
    Psychopharmacology (Berl); 1989; 99(2):276-81. PubMed ID: 2508166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic function during lithium augmentation of refractory depression.
    McCance-Katz E; Price LH; Charney DS; Heninger GR
    Psychopharmacology (Berl); 1992; 108(1-2):93-7. PubMed ID: 1410150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
    Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
    Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life events and the dexamethasone suppression test in affective illness.
    Mendlewicz J; Charon F; Linkowski P
    J Affect Disord; 1986; 10(3):203-6. PubMed ID: 2943773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects.
    Cappiello A; Malison RT; McDougle CJ; Vegso SJ; Charney DS; Heninger GR; Price LH
    Neuropsychopharmacology; 1996 Nov; 15(5):475-83. PubMed ID: 8914120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium and serotonin function: implications for the serotonin hypothesis of depression.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Psychopharmacology (Berl); 1990; 100(1):3-12. PubMed ID: 2404294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.